2 adult patients received Bivalent booster on 29-Nov-2022 from the vial received as liquid on 05-Oct-2022 (Thawed during transport in a cooler); No adverse event; Received Expired Bivalent vaccine after 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Bivalent vaccine after 30-day Use By Date), PRODUCT STORAGE ERROR (2 adult patients received Bivalent booster on 29-Nov-2022 from the vial received as liquid on 05-Oct-2022 (Thawed during transport in a cooler)) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 050D22A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Bivalent vaccine after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (2 adult patients received Bivalent booster on 29-Nov-2022 from the vial received as liquid on 05-Oct-2022 (Thawed during transport in a cooler)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Bivalent vaccine after 30-day Use By Date), PRODUCT STORAGE ERROR (2 adult patients received Bivalent booster on 29-Nov-2022 from the vial received as liquid on 05-Oct-2022 (Thawed during transport in a cooler)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received Expired Bivalent vaccine after 30-day Use By Date) and PRODUCT STORAGE ERROR (2 adult patients received Bivalent booster on 29-Nov-2022 from the vial received as liquid on 05-Oct-2022 (Thawed during transport in a cooler)).    No concomitant medication was provided.  Reportedly, included both individual vials or unbroken cartons. Bivalent vial size included 2.5ml and a patient received Bivalent booster on 29-Nov-2022 from the vial received as liquid on 05-Oct-2022 (Thawed during transport in a cooler). The vial did not underwent any temperature excursions.   Treatment medication was not provided by the reporter.  This case is for adult patient 2 from 2 adult patients received bivalent booster on 29-Nov-2022.   This case was linked to US-MODERNATX, INC.-MOD-2022-682038, US-MODERNATX, INC.-MOD-2022-682093, US-MODERNATX, INC.-MOD-2022-682096, US-MODERNATX, INC.-MOD-2022-682097, US-MODERNATX, INC.-MOD-2022-682098, US-MODERNATX, INC.-MOD-2022-682101, US-MODERNATX, INC.-MOD-2022-682103, US-MODERNATX, INC.-MOD-2022-682111, US-MODERNATX, INC.-MOD-2022-682120, US-MODERNATX, INC.-MOD-2022-682134, US-MODERNATX, INC.-MOD-2022-682171, US-MODERNATX, INC.-MOD-2022-682173, US-MODERNATX, INC.-MOD-2022-682174 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 02-Dec-2022: Live follow up received contain no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-682038:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682093:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682096:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682097:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682098:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682101:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682103:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682111:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682120:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682134:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682171:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682173:Monovalent (Same reporter) US-MODERNATX, INC.-MOD-2022-682174:Patient 1